Catalyst Wire Dossier Catalyst Wire Dossier

CSB-001 Ophthalmic Solution 0.1%

CSB-001 · Claris Biotherapeutics, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CSB-001 Ophthalmic Solution 0.1%, covering 2024-09-19 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars [Phase 1]

See pricing